---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-034773"
form_type: "8-K"
ticker: "ORKA"
cik: "0000907654"
company_name: "Oruka Therapeutics, Inc."
filed_at: "2022-10-20T23:59:59+00:00"
generated_at: "2026-06-23T02:30:54.691742+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# ARCA biopharma sets 2022 annual meeting for Dec 15, record date Oct 25

## Summary
- Shareholder proposals/nominations due by Oct 24, 2022 due to meeting being >30 days from prior year.
- Proxy materials expected to be available on or about Nov 4, 2022.
- Record date for voting set as Oct 25, 2022.

## SEC filing metadata
- accession: 0001564590-22-034773
- form_type: 8-K
- ticker: ORKA
- cik: 0000907654
- company_name: Oruka Therapeutics, Inc.
- filed_at: 2022-10-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/907654/000156459022034773/0001564590-22-034773-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/907654/000156459022034773/abio-8k_20221020.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-034773
- JSON: https://secwatch.observer/filing/0001564590-22-034773.json
- Plain text: https://secwatch.observer/filing/0001564590-22-034773.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.